Bazedoxifene/Colecalciferol

巴多昔芬/胆骨化醇

Report date: 2023/03/17 17:34:00

Base Information

Drug NameBazedoxifene/Colecalciferol
Drug Alias NameHOB-078HDDO-16141/HDDO-16142HDDO-1614
ClassificationSmall molecules
Mechanisms of ActionEstrogen receptor alpha agonistsVitamin D receptor agonistsEstrogen receptor beta agonists
TargetsEstrogen receptor alphaEstrogen receptor betaVitamin D receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes ColecalciferolBazedoxifene Acetate
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHyundai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHyundai Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A